← all drugs
Fondaparinux Sodium Injection
being discontinued · Hematology · Snapshot: 2026-08-25
- Manufacturers listed
- Jiangsu Hengrui Pharmaceuticals Co. (US Agent eVenus Pharmaceutical Laboratories, Inc.)
- Machine-readable
- JSON for this drug
Presentations (4)
| Presentation | Company | Availability | Updated |
|---|---|---|---|
| Fondaparinux Sodium, Injection, 7.5 mg/.6 mL (NDC 0781-3465-95) | Jiangsu Hengrui Pharmaceuticals Co. (US Agent eVenus Pharmaceutical Laboratories, Inc.) | unknown | 09/29/2025 |
| Fondaparinux Sodium, Injection, 2.5 mg/.5 mL (NDC 0781-3443-95) | Jiangsu Hengrui Pharmaceuticals Co. (US Agent eVenus Pharmaceutical Laboratories, Inc.) | unknown | 09/29/2025 |
| Fondaparinux Sodium, Injection, 10 mg/.8 mL (NDC 0781-3476-95) | Jiangsu Hengrui Pharmaceuticals Co. (US Agent eVenus Pharmaceutical Laboratories, Inc.) | unknown | 09/29/2025 |
| Fondaparinux Sodium, Injection, 5 mg/.4 mL (NDC 0781-3454-95) | Jiangsu Hengrui Pharmaceuticals Co. (US Agent eVenus Pharmaceutical Laboratories, Inc.) | unknown | 09/29/2025 |
History
Daily change tracking began 2026-08-25 (index founding). Status flips and availability changes will accumulate here.
Not medical advice. ShortSupply republishes the FDA's drug-shortage data with history added. Talk to your pharmacist or prescriber about your situation — never change medication based on this site.